应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01672 歌礼制药-B
耶稣受难节休市 03-28 16:08:03
1.430
+0.020
+1.42%
最高
1.450
最低
1.400
成交量
14.00万
今开
1.410
昨收
1.410
日振幅
3.55%
总市值
14.48亿
流通市值
14.48亿
总股本
10.13亿
成交额
19.92万
换手率
0.01%
流通股本
10.13亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
歌礼制药-B(01672)下跌5.33%,报1.42元/股
金融界 · 03-27 14:21
歌礼制药-B(01672)下跌5.33%,报1.42元/股
国元国际:创新药研发取得优异成果,建议积极关注歌礼制药(1672.HK)
权证网 · 03-27 13:34
国元国际:创新药研发取得优异成果,建议积极关注歌礼制药(1672.HK)
2024财报|重押NASH管线,歌礼制药能否扭转“无药可卖”局面
华尔街见闻 · 03-27 10:30
2024财报|重押NASH管线,歌礼制药能否扭转“无药可卖”局面
歌礼制药-B盘中异动 早盘股价大跌6.00%
自选股智能写手 · 03-27 09:37
歌礼制药-B盘中异动 早盘股价大跌6.00%
《公司业绩》歌礼制药(01672.HK)全年亏损收窄至1.45亿人民币
阿斯达克财经 · 03-26
《公司业绩》歌礼制药(01672.HK)全年亏损收窄至1.45亿人民币
歌礼制药-B(01672.HK)年度亏损减少至1.45亿元
港股那点事 · 03-25
歌礼制药-B(01672.HK)年度亏损减少至1.45亿元
歌礼制药-B(01672)发布2023年度业绩,收入约5660万元,同比增加4.6%
智通财经 · 03-25
歌礼制药-B(01672)发布2023年度业绩,收入约5660万元,同比增加4.6%
歌礼制药-B(01672)下跌5.03%,报1.51元/股
金融界 · 03-25
歌礼制药-B(01672)下跌5.03%,报1.51元/股
歌礼制药-B盘中异动 下午盘大幅下挫5.09%报1.510港元
自选股智能写手 · 03-25
歌礼制药-B盘中异动 下午盘大幅下挫5.09%报1.510港元
多家主要供应商“兼职”客户,都正生物资产负债率常年高于同行
瑞财网 · 03-22
多家主要供应商“兼职”客户,都正生物资产负债率常年高于同行
歌礼制药-B03月19日主力资金流出31万元 连续3日减仓
自选股智能写手 · 03-19
歌礼制药-B03月19日主力资金流出31万元 连续3日减仓
歌礼制药-B盘中异动 早盘股价大涨5.49%报1.730港元
自选股智能写手 · 03-15
歌礼制药-B盘中异动 早盘股价大涨5.49%报1.730港元
歌礼制药-B(01672)股价上升5.488%,现价港币$1.73
阿斯达克财经 · 03-15
歌礼制药-B(01672)股价上升5.488%,现价港币$1.73
歌礼制药-B盘中异动 早盘快速拉升5.36%报1.770港元
自选股智能写手 · 03-14
歌礼制药-B盘中异动 早盘快速拉升5.36%报1.770港元
歌礼制药-B(01672)股价上升5.952%,现价港币$1.78
阿斯达克财经 · 03-14
歌礼制药-B(01672)股价上升5.952%,现价港币$1.78
歌礼制药-B(01672)上涨5.16%,报1.63元/股
金融界 · 03-12
歌礼制药-B(01672)上涨5.16%,报1.63元/股
歌礼制药-B盘中异动 急速上涨5.16%报1.630港元
自选股智能写手 · 03-12
歌礼制药-B盘中异动 急速上涨5.16%报1.630港元
歌礼制药-B(01672)股价上升5.161%,现价港币$1.63
阿斯达克财经 · 03-12
歌礼制药-B(01672)股价上升5.161%,现价港币$1.63
港股公告掘金 | 顺丰同城预计2023年度持续经营业务净利润不低于约6000万元
智通财经 · 03-11
港股公告掘金 | 顺丰同城预计2023年度持续经营业务净利润不低于约6000万元
歌礼制药-B(01672.HK)在美国皮肤病学会年会上展示治疗痤疮药物研究结果
阿斯达克财经 · 03-11
歌礼制药-B(01672.HK)在美国皮肤病学会年会上展示治疗痤疮药物研究结果
加载更多
公司概况
公司名称:
歌礼制药-B
所属市场:
SEHK
上市日期:
--
主营业务:
歌礼制药有限公司是一家主要从事生物制品研发的中国公司。该公司主要专注于抗病毒、癌症及脂肪肝疾 病三大治疗领域。该公司的主要产品包括抗丙型肝炎病毒(HCV)、人类免疫缺陷病毒(HIV)及乙型肝炎(HBV)药物。
发行价格:
--
{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":1.43,"timestamp":1711613283013,"preClose":1.41,"halted":0,"volume":140000,"delay":0,"floatShares":1012758000,"shares":1012758000,"eps":-0.14518745,"marketStatus":"耶稣受难节休市","marketStatusCode":7,"change":0.02,"latestTime":"03-28 16:08:03","open":1.41,"high":1.45,"low":1.4,"amount":199200,"amplitude":0.035461,"askPrice":1.43,"askSize":4000,"bidPrice":1.42,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.14518745309821784,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1712021400000},"adr":0,"listingDate":1533052800000,"adjPreClose":1.41,"openAndCloseTimeList":[[1711589400000,1711598400000],[1711602000000,1711612800000]],"volumeRatio":0.21033653845837838,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672/","defaultTab":"news","newsList":[{"id":"2422393164","title":"歌礼制药-B(01672)下跌5.33%,报1.42元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422393164","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422393164?lang=zh_cn&edition=full","pubTime":"2024-03-27 14:21","pubTimestamp":1711520487,"startTime":"0","endTime":"0","summary":"3月27日,歌礼制药-B(01672)盘中下跌5.33%,截至14:21,报1.42元/股,成交114.56万元。歌礼制药是一家致力于为抗病毒、癌症和脂肪肝等领域提供创新治疗方案的生物科技公司,覆盖从新药研发到生产和商业化的完整价值链。公司以高度一体化的抗病毒平台为基础,专注于为慢性丙肝、慢性乙肝和艾滋病患者提供创新药物,使其得到可负担的医疗解决方案。截至2023年年报,歌礼制药-B营业总收入5659.6万元、净利润-1.45亿元。3月25日,2023财年年报归属股东应占溢利-1.447亿人民币,同比增长54.04%,基本每股收益-0.1347人民币。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/27142140012798.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422935387","title":"国元国际:创新药研发取得优异成果,建议积极关注歌礼制药(1672.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2422935387","media":"权证网","top":-1,"share":"https://www.laohu8.com/m/news/2422935387?lang=zh_cn&edition=full","pubTime":"2024-03-27 13:34","pubTimestamp":1711517660,"startTime":"0","endTime":"0","summary":"近日,国元国际发布歌礼制药研报,并建议积极关注。研报指出,公司创新药研发取得优异成果,现金储备充足。ASC41NASH的II期期中分析数据12周治疗显著降低肝脂肪及炎症。国元国际认为,公司ASC40治疗痤疮,空间广阔。目前市值仅15亿港元,而且公司注重投资者回报,已经回购注销1.3亿港元股票,公司价值严重低估,建议积极关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032713342787badc7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032713342787badc7b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422871985","title":"2024财报|重押NASH管线,歌礼制药能否扭转“无药可卖”局面","url":"https://stock-news.laohu8.com/highlight/detail?id=2422871985","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2422871985?lang=zh_cn&edition=full","pubTime":"2024-03-27 10:30","pubTimestamp":1711506647,"startTime":"0","endTime":"0","summary":"诉讼风波难解","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/content_default_9.jpg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/content_default_9.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3711414","is_publish_highlight":false,"gpt_icon":0},{"id":"2422601986","title":"歌礼制药-B盘中异动 早盘股价大跌6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422601986","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422601986?lang=zh_cn&edition=full","pubTime":"2024-03-27 09:37","pubTimestamp":1711503470,"startTime":"0","endTime":"0","summary":"2024年03月27日早盘09时37分,歌礼制药-B股票出现异动,股价大幅下跌6.00%。截至发稿,该股报1.410港元/股,成交量23.6万股,换手率0.02%,振幅6.00%。歌礼制药-B股票所在的生物技术行业中,整体跌幅为0.40%。消息层面,截至09时37分,《歌礼制药-B发布2023年度业绩,收入约5660万元,同比增加4.6%》资讯为影响歌礼制药-B的重要信息。截至2023年12月31日,集团的现金及现金等价物以及定期存款约为22.746亿元,其预计足以支持其直至2028年的研发活动及营运。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032709375187e7bf6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032709375187e7bf6a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422528313","title":"《公司业绩》歌礼制药(01672.HK)全年亏损收窄至1.45亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2422528313","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422528313?lang=zh_cn&edition=full","pubTime":"2024-03-26 00:22","pubTimestamp":1711383720,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672.HK) 公布2023年止年度业绩,收入录得5,660万人民币(下同),按年增加4.6%。亏损由上年度3.15亿元,收窄至1.45亿元,每股亏损13.47分。不派末期息。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/22中期业绩无派息2023/03/20末期业绩无派息 2022/08/22中期业绩无派息 2022/03/22末期业绩无派息 AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20200428112816451_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20200428112816451_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1336777/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422172175","title":"歌礼制药-B(01672.HK)年度亏损减少至1.45亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422172175","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2422172175?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:27","pubTimestamp":1711373247,"startTime":"0","endTime":"0","summary":"格隆汇3月25日丨歌礼制药-B公告,截至2023年12月31日止年度,公司收入由上年度的约人民币54.1百万元增加4.6%至约人民币56.6百万元。集团的总收入由上年度的约人民币166.1百万元增加45.2%至约人民币241.2百万元。集团的研发成本由上年度的约人民币267.1百万元减少18.8%至该年度的约人民币216.8百万元,主要由于临床及临床前项目研发效率提高;及无形资产的折旧及摊销成本减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inappxsk1430773.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-25/doc-inappxsk1430773.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422512713","title":"歌礼制药-B(01672)发布2023年度业绩,收入约5660万元,同比增加4.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422512713","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422512713?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:15","pubTimestamp":1711372553,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B 发布截至2023年12月31日止年度业绩,集团的收入由2022年度的约5410万元增加4.6%至2023年度的约5660万元,乃由于利托那韦产品产生的收入增加约4940万元,但大部分被推广服务收入减少约4040万元所抵销,原因为集团终止向上海罗氏制药有限公司提供派罗欣在中国的推广服务。截至2023年12月31日,集团的现金及现金等价物以及定期存款约为22.746亿元,其预计足以支持其直至2028年的研发活动及营运。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091816.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422963564","title":"歌礼制药-B(01672)下跌5.03%,报1.51元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422963564","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422963564?lang=zh_cn&edition=full","pubTime":"2024-03-25 15:59","pubTimestamp":1711353584,"startTime":"0","endTime":"0","summary":"3月25日,歌礼制药-B(01672)盘中下跌5.03%,截至15:59,报1.51元/股,成交100.1万元。歌礼制药是一家致力于为抗病毒、癌症和脂肪肝等领域提供创新治疗方案的生物科技公司,覆盖从新药研发到生产和商业化的完整价值链。公司以高度一体化的抗病毒平台为基础,专注于为慢性丙肝、慢性乙肝和艾滋病患者提供创新药物,使其得到可负担的医疗解决方案。截至2023年中报,歌礼制药-B营业总收入4650.6万元、净利润-1655.9万元。3月25日,歌礼制药-B披露2023财年年报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/25155939980005.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422656393","title":"歌礼制药-B盘中异动 下午盘大幅下挫5.09%报1.510港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422656393","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422656393?lang=zh_cn&edition=full","pubTime":"2024-03-25 15:10","pubTimestamp":1711350642,"startTime":"0","endTime":"0","summary":"2024年03月25日下午盘15时10分,歌礼制药-B股票出现异动,股价急速下挫5.09%。截至发稿,该股报1.510港元/股,成交量43.8万股,换手率0.04%,振幅6.92%。资金方面,该股资金流入3.013万港元,流出48.737万港元。歌礼制药-B股票所在的生物技术行业中,整体涨幅为0.90%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325151042791c8efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325151042791c8efb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421983861","title":"多家主要供应商“兼职”客户,都正生物资产负债率常年高于同行","url":"https://stock-news.laohu8.com/highlight/detail?id=2421983861","media":"瑞财网","top":-1,"share":"https://www.laohu8.com/m/news/2421983861?lang=zh_cn&edition=full","pubTime":"2024-03-22 16:39","pubTimestamp":1711096766,"startTime":"0","endTime":"0","summary":"瑞财经 吴文婷 3月22日消息,长沙都正生物科技股份有限公司(以下简称“都正生物”)于近日披露首次公开发行股票并在创业板上市招股说明书。据查阅,2020年-2022年,都正生物实现营业收入分别为1.43亿元、2.17亿元、3.47亿元;归属于母公司所有者的净利润分别为2448.28万元、3700.34万元、7777.28万元。 都正生物的主要客...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/O30nrziKFChpTDwQxrdLOX3z9NrM20S8K3Ag8HVsdb1zIAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O30nrziKFChpTDwQxrdLOX3z9NrM20S8K3Ag8HVsdb1zIAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240322A06UO600","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240322A06UO600","is_publish_highlight":false,"gpt_icon":0},{"id":"2420211979","title":"歌礼制药-B03月19日主力资金流出31万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2420211979","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420211979?lang=zh_cn&edition=full","pubTime":"2024-03-19 16:16","pubTimestamp":1710836188,"startTime":"0","endTime":"0","summary":"03月19日, 歌礼制药-B股价跌1.23%,报收1.60元,成交金额108万元,换手率0.07%,振幅3.09%,量比0.45。歌礼制药-B今日主力资金净流出31万元,连续3日净流出,上一交易日主力净流出30万元,今日环比增加3.33%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为3.65%。该股近5个交易日下跌6.43%,主力资金累计净流出97万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出60万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319161713879730d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319161713879730d5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419787967","title":"歌礼制药-B盘中异动 早盘股价大涨5.49%报1.730港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419787967","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419787967?lang=zh_cn&edition=full","pubTime":"2024-03-15 09:54","pubTimestamp":1710467653,"startTime":"0","endTime":"0","summary":"2024年03月15日早盘09时54分,歌礼制药-B股票出现波动,股价大幅拉升5.49%。截至发稿,该股报1.730港元/股,成交量32.7万股,换手率0.03%,振幅3.05%。资金方面,该股资金流入32.273万港元,流出20.721万港元。歌礼制药-B股票所在的生物技术行业中,整体跌幅为0.34%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315095413791aaa69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315095413791aaa69&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419508998","title":"歌礼制药-B(01672)股价上升5.488%,现价港币$1.73","url":"https://stock-news.laohu8.com/highlight/detail?id=2419508998","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2419508998?lang=zh_cn&edition=full","pubTime":"2024-03-15 09:54","pubTimestamp":1710467640,"startTime":"0","endTime":"0","summary":"[上升股]歌礼制药-B(01672) 股价在上午09:54比前收市价上升5.488%,现股价为港币$1.73。至目前为止,今日最高价为$1.73,而最低价为$1.68。总成交量为32.7万股,总成交金额为港币$55.532万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240315560/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2419922476","title":"歌礼制药-B盘中异动 早盘快速拉升5.36%报1.770港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419922476","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419922476?lang=zh_cn&edition=full","pubTime":"2024-03-14 09:40","pubTimestamp":1710380438,"startTime":"0","endTime":"0","summary":"2024年03月14日早盘09时40分,歌礼制药-B股票出现异动,股价快速拉升5.36%。截至发稿,该股报1.770港元/股,成交量6.7万股,换手率0.01%,振幅5.95%。资金方面,该股资金流入10.775万港元,流出0港元。歌礼制药-B股票所在的生物技术行业中,整体涨幅为1.89%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031409403887e78b02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031409403887e78b02&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419227697","title":"歌礼制药-B(01672)股价上升5.952%,现价港币$1.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2419227697","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2419227697?lang=zh_cn&edition=full","pubTime":"2024-03-14 09:40","pubTimestamp":1710380400,"startTime":"0","endTime":"0","summary":"[上升股]歌礼制药-B(01672) 股价在上午09:40比前收市价上升5.952%,现股价为港币$1.78。至目前为止,今日最高价为$1.78,而最低价为$1.69。总成交量为4.6万股,总成交金额为港币$8.073万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240314385/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2418329448","title":"歌礼制药-B(01672)上涨5.16%,报1.63元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2418329448","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2418329448?lang=zh_cn&edition=full","pubTime":"2024-03-12 10:40","pubTimestamp":1710211253,"startTime":"0","endTime":"0","summary":"3月12日,歌礼制药-B(01672)盘中上涨5.16%,截至10:40,报1.63元/股,成交115.51万元。歌礼制药是一家致力于为抗病毒、癌症和脂肪肝等领域提供创新治疗方案的生物科技公司,覆盖从新药研发到生产和商业化的完整价值链。公司以高度一体化的抗病毒平台为基础,专注于为慢性丙肝、慢性乙肝和艾滋病患者提供创新药物,使其得到可负担的医疗解决方案。截至2023年中报,歌礼制药-B营业总收入4650.6万元、净利润-1655.9万元。3月25日,歌礼制药-B将披露2023财年年报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/12104039813807.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2418340764","title":"歌礼制药-B盘中异动 急速上涨5.16%报1.630港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418340764","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418340764?lang=zh_cn&edition=full","pubTime":"2024-03-12 09:45","pubTimestamp":1710207910,"startTime":"0","endTime":"0","summary":"2024年03月12日早盘09时45分,歌礼制药-B股票出现波动,股价急速上涨5.16%。截至发稿,该股报1.630港元/股,成交量34.5万股,换手率0.03%,振幅5.81%。资金方面,该股资金流入46.085万港元,流出0港元。机构评级方面,在所有3家参与评级的机构中,67%的券商给予买入建议,33%的券商给予持有建议,无券商给予卖出建议。歌礼制药-B股票所在的生物技术行业中,整体涨幅为0.62%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403120945107919871d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403120945107919871d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418328067","title":"歌礼制药-B(01672)股价上升5.161%,现价港币$1.63","url":"https://stock-news.laohu8.com/highlight/detail?id=2418328067","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2418328067?lang=zh_cn&edition=full","pubTime":"2024-03-12 09:45","pubTimestamp":1710207900,"startTime":"0","endTime":"0","summary":"[上升股]歌礼制药-B(01672) 股价在上午09:45比前收市价上升5.161%,现股价为港币$1.63。至目前为止,今日最高价为$1.63,而最低价为$1.54。总成交量为33.9万股,总成交金额为港币$54.611万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240312621/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2418554361","title":"港股公告掘金 | 顺丰同城预计2023年度持续经营业务净利润不低于约6000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418554361","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2418554361?lang=zh_cn&edition=full","pubTime":"2024-03-11 22:59","pubTimestamp":1710169195,"startTime":"0","endTime":"0","summary":"重大事项:ESR(01821)附属拟出售ARA私募基金业务的权益 预计实现收益约5000万美元歌礼制药-B(01672)宣布在2024年美国皮肤病学会(AAD)年会展示FASN抑制剂ASC40治疗痤疮II期研究最终结果乐普生物-B(02157):MRG004A 用于治疗胰腺癌获FDA授予快速通道资格来凯医药-B(02105)已向美国食品和药物管理局提交LAE102肥胖症新药临床试验申请科伦博泰生物","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1084820.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2418827359","title":"歌礼制药-B(01672.HK)在美国皮肤病学会年会上展示治疗痤疮药物研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2418827359","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2418827359?lang=zh_cn&edition=full","pubTime":"2024-03-11 08:55","pubTimestamp":1710118500,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672.HK) 公布,在美国圣叠戈举行的2024年美国皮肤病学会(AAD)年会上以壁报形式展示同类首创脂肪酸合成酶(FASN)抑制剂ASC40治疗痤疮的II期研究最终结果。结果显示,在所有剂量下,上述疗效指标从第2周到第12周普遍有所改善。每日一次50毫克显示出最佳疗效。根据该2期试验的疗效和安全性数据,每日一次50毫克ASC40,为期12周治疗的3期临床试验已启动。公司已从Sagimet Biosciences Inc.获得ASC40在大中华区的开发、生产和商业化独家权益。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20200428144141002_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20200428144141002_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1332167/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":-0.1118},{"period":"1month","weight":-0.2143},{"period":"3month","weight":-0.0205},{"period":"6month","weight":-0.2741},{"period":"1year","weight":-0.4723},{"period":"ytd","weight":-0.0205}],"compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0149},{"period":"3month","weight":-0.0297},{"period":"6month","weight":-0.0712},{"period":"1year","weight":-0.1808},{"period":"ytd","weight":-0.0297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事生物制品研发的中国公司。该公司主要专注于抗病毒、癌症及脂肪肝疾 病三大治疗领域。该公司的主要产品包括抗丙型肝炎病毒(HCV)、人类免疫缺陷病毒(HIV)及乙型肝炎(HBV)药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.102992},{"month":2,"riseRate":0.666667,"avgChangeRate":0.004802},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.105976},{"month":4,"riseRate":0.6,"avgChangeRate":-0.02198},{"month":5,"riseRate":0.4,"avgChangeRate":-0.017072},{"month":6,"riseRate":0.4,"avgChangeRate":-0.002776},{"month":7,"riseRate":0.4,"avgChangeRate":-0.074118},{"month":8,"riseRate":0.2,"avgChangeRate":-0.0588},{"month":9,"riseRate":0,"avgChangeRate":-0.108951},{"month":10,"riseRate":0.5,"avgChangeRate":-0.070866},{"month":11,"riseRate":0.833333,"avgChangeRate":0.149725},{"month":12,"riseRate":0.5,"avgChangeRate":-0.003643}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}